Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03684837Not ApplicableUnknown

D Vitamine and Whole Body Vibration in Functional Outcomes

Role: lead

NCT03684330Not ApplicableUnknown

Vitamin D Supplementation and WBV in Inflammatory Markers, Strength and Body Composition in Old Patients With COPD

Role: lead

NCT03679325Not ApplicableUnknown

Evaluation of Cardiac Variability After a Vitamine D Protocol and Whole Body Vibration

Role: lead

NCT03542929Not ApplicableCompleted

Acute Whole Body Vibration Change the Glycemic and Lactate Levels

Role: lead

NCT02774577Not ApplicableCompleted

Oxygen Consumption After Acute Whole Body Vibration Session

Role: lead

NCT01681719Not ApplicableCompleted

Ergospirometric Values and WBV in Elderly

Role: lead

All 6 trials loaded